| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.96 | 0.002 | 0.96 | Bruton tyrosine kinase inhibitor | 0.732 0.003 DBMET02878 0.598 0.003 DBMET02881 0.473 0.004 DBMET02882 0.178 0.006 DBMET02885 0.92 0.002 DBMET02888 0.611 0.003 DBMET02889 0.911 0.002 DBMET02890 0.476 0.004 DBMET02879 0.419 0.004 DBMET02880 0.405 0.004 DBMET02883 0.51 0.003 DBMET02884 0.26 0.005 DBMET02886 0.325 0.004 DBMET02887 | ||
| 0.857 | 0.005 | 0.857 | Tyrosine kinase inhibitor | 0.489 0.019 DBMET02878 0.264 0.05 DBMET02881 0.363 0.033 DBMET02882 0.822 0.005 DBMET02888 0.228 0.06 DBMET02889 0.747 0.005 DBMET02890 0.53 0.015 DBMET02879 0.273 0.048 DBMET02880 0.308 0.041 DBMET02883 0.443 0.023 DBMET02884 0.135 0.098 DBMET02887 | ||
| 0.81 | 0.014 | 0.81 | Antiinflammatory | 0.713 0.028 DBMET02878 0.73 0.026 DBMET02881 0.559 0.065 DBMET02882 0.472 0.1 DBMET02885 0.718 0.028 DBMET02888 0.552 0.067 DBMET02889 0.808 0.014 DBMET02890 0.659 0.039 DBMET02879 0.706 0.03 DBMET02880 0.59 0.056 DBMET02883 0.588 0.057 DBMET02884 0.473 0.099 DBMET02886 0.557 0.066 DBMET02887 | ||
| 0.631 | 0.009 | 0.631 | Immunomodulator | 0.487 0.025 DBMET02878 0.48 0.026 DBMET02881 0.494 0.024 DBMET02882 0.603 0.011 DBMET02885 0.54 0.018 DBMET02888 0.232 0.13 DBMET02889 0.614 0.01 DBMET02890 0.557 0.016 DBMET02879 0.411 0.041 DBMET02880 0.591 0.012 DBMET02883 0.552 0.017 DBMET02884 0.553 0.016 DBMET02886 0.588 0.013 DBMET02887 | ||
| 0.502 | 0.031 | 0.502 | Toll-Like receptor agonist | 0.222 0.177 DBMET02885 0.449 0.043 DBMET02888 0.499 0.032 DBMET02890 0.362 0.076 DBMET02879 0.27 0.131 DBMET02880 0.244 0.154 DBMET02883 0.342 0.086 DBMET02884 0.304 0.108 DBMET02886 0.281 0.123 DBMET02887 | ||
| 0.498 | 0.032 | 0.498 | Toll-Like receptor 7 agonist | 0.446 0.044 DBMET02888 0.496 0.033 DBMET02890 0.351 0.081 DBMET02879 0.258 0.141 DBMET02880 0.237 0.159 DBMET02883 0.328 0.094 DBMET02884 0.22 0.178 DBMET02886 0.24 0.156 DBMET02887 | ||
| 0.259 | 0.026 | 0.305 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.249 0.029 DBMET02882 0.247 0.029 DBMET02888 0.233 0.033 DBMET02890 0.163 0.055 DBMET02880 0.225 0.035 DBMET02883 0.305 0.017 DBMET02884 0.128 0.076 DBMET02887 | DBMET02884 | |
| 0.228 | 0.075 | 0.24 | MAP-kinase-activated kinase 5 inhibitor | 0.212 0.09 DBMET02882 0.213 0.088 DBMET02888 0.202 0.101 DBMET02890 0.176 0.139 DBMET02880 0.19 0.116 DBMET02883 0.24 0.066 DBMET02884 | DBMET02884 | |
| 0.165 | 0.015 | 0.165 | Glutamate (mGluR) antagonist | 0.124 0.024 DBMET02878 0.149 0.018 DBMET02888 0.083 0.046 DBMET02889 0.106 0.032 DBMET02890 0.103 0.033 DBMET02879 0.079 0.05 DBMET02884 | ||
| 0.151 | 0.013 | 0.151 | Glutamate (mGluR group I) antagonist | 0.127 0.018 DBMET02878 0.112 0.022 DBMET02888 0.089 0.032 DBMET02889 0.088 0.032 DBMET02890 0.099 0.027 DBMET02879 0.075 0.043 DBMET02884 | ||
| 0.189 | 0.054 | 0.225 | Protein kinase (CK1) gamma 3 inhibitor | 0.172 0.068 DBMET02882 0.225 0.035 DBMET02888 0.165 0.074 DBMET02890 0.155 0.084 DBMET02880 0.163 0.076 DBMET02883 0.197 0.049 DBMET02884 | DBMET02888 | |
| 0.213 | 0.088 | 0.313 | MAP kinase kinase 3 inhibitor | 0.302 0.007 DBMET02878 0.275 0.015 DBMET02881 0.196 0.135 DBMET02882 0.215 0.085 DBMET02888 0.202 0.116 DBMET02889 0.204 0.111 DBMET02890 0.293 0.009 DBMET02879 0.313 0.005 DBMET02880 0.191 0.151 DBMET02883 0.201 0.12 DBMET02884 0.184 0.176 DBMET02887 | DBMET02880 | |
| 0.207 | 0.082 | 0.515 | ErbB-1 antagonist | 0.51 0.008 DBMET02878 0.515 0.008 DBMET02881 0.212 0.077 DBMET02888 0.198 0.091 DBMET02889 0.188 0.103 DBMET02890 0.475 0.01 DBMET02879 | DBMET02881 | |
| 0.152 | 0.05 | 0.158 | Glutamate receptor antagonist | 0.117 0.077 DBMET02878 0.114 0.081 DBMET02881 0.158 0.045 DBMET02888 0.122 0.072 DBMET02889 0.125 0.069 DBMET02890 0.12 0.074 DBMET02879 | DBMET02888 | |
| 0.126 | 0.03 | 0.149 | Insulin growth factor antagonist | 0.114 0.037 DBMET02882 0.118 0.035 DBMET02888 0.076 0.074 DBMET02890 0.132 0.028 DBMET02883 0.149 0.023 DBMET02884 | DBMET02884 | |
| 0.277 | 0.184 | 0.383 | Cyclophilin D inhibitor | 0.248 0.215 DBMET02888 0.383 0.101 DBMET02890 | DBMET02890 | |
| 0.121 | 0.029 | 0.145 | Insulin like growth factor 1 antagonist | 0.109 0.036 DBMET02882 0.112 0.033 DBMET02888 0.073 0.072 DBMET02890 0.126 0.027 DBMET02883 0.145 0.022 DBMET02884 | DBMET02884 | |
| 0.171 | 0.085 | 0.184 | TRKC antagonist | 0.138 0.112 DBMET02882 0.168 0.087 DBMET02888 0.15 0.101 DBMET02890 0.136 0.115 DBMET02883 0.184 0.076 DBMET02884 | DBMET02884 | |
| 0.093 | 0.011 | 0.093 | Glutamate (mGluR5) antagonist | 0.067 0.018 DBMET02878 0.065 0.02 DBMET02888 0.073 0.016 DBMET02889 0.049 0.031 DBMET02890 0.052 0.028 DBMET02879 0.041 0.04 DBMET02884 | ||
| 0.15 | 0.069 | 0.178 | Growth factor antagonist | 0.178 0.054 DBMET02888 0.117 0.095 DBMET02890 | DBMET02888 | |
| 0.104 | 0.029 | 0.162 | mTOR complex 2 inhibitor | 0.126 0.015 DBMET02882 0.078 0.073 DBMET02888 0.085 0.057 DBMET02890 0.118 0.019 DBMET02883 0.162 0.007 DBMET02884 | DBMET02884 | |
| 0.149 | 0.074 | 0.163 | NOS3 expression enhancer | 0.128 0.101 DBMET02888 0.124 0.108 DBMET02889 0.163 0.061 DBMET02890 0.13 0.097 DBMET02883 0.124 0.108 DBMET02884 | DBMET02890 | |
| 0.069 | 0.005 | 0.069 | Carnitine palmitoyltransferase 1A inhibitor | 0.054 0.006 DBMET02882 0.028 0.021 DBMET02885 0.061 0.005 DBMET02889 0.028 0.021 DBMET02890 0.05 0.007 DBMET02883 0.062 0.005 DBMET02884 0.034 0.014 DBMET02886 0.041 0.009 DBMET02887 | ||
| 0.064 | 0.003 | 0.088 | HCV NS5A inhibitor | 0.058 0.004 DBMET02882 0.037 0.007 DBMET02885 0.088 0.002 DBMET02889 0.029 0.017 DBMET02890 0.055 0.004 DBMET02883 0.064 0.003 DBMET02884 0.04 0.005 DBMET02886 0.043 0.005 DBMET02887 | DBMET02889 | |
| 0.083 | 0.024 | 0.083 | Tyrosine-protein kinase EMT inhibitor | 0.083 0.024 DBMET02878 0.059 0.039 DBMET02888 0.058 0.04 DBMET02890 0.059 0.039 DBMET02879 | ||
| 0.14 | 0.085 | 0.245 | Insulin secretagoues | 0.16 0.065 DBMET02878 0.221 0.027 DBMET02881 0.245 0.02 DBMET02888 0.155 0.07 DBMET02889 0.156 0.068 DBMET02890 0.159 0.066 DBMET02879 0.12 0.112 DBMET02880 0.142 0.083 DBMET02883 | DBMET02888 | |
| 0.134 | 0.08 | 0.186 | Protein kinase C nu inhibitor | 0.117 0.096 DBMET02882 0.186 0.053 DBMET02888 0.119 0.094 DBMET02890 0.134 0.08 DBMET02880 0.119 0.094 DBMET02883 0.155 0.067 DBMET02884 | DBMET02888 | |
| 0.13 | 0.078 | 0.164 | Lck kinase inhibitor | 0.164 0.057 DBMET02888 0.114 0.09 DBMET02890 | DBMET02888 | |
| 0.111 | 0.065 | 0.121 | MAP kinase 13 inhibitor | 0.101 0.079 DBMET02882 0.12 0.055 DBMET02888 0.121 0.055 DBMET02884 | DBMET02884 | |
| 0.084 | 0.038 | 0.093 | Protein kinase B beta inhibitor | 0.075 0.049 DBMET02882 0.093 0.03 DBMET02888 0.075 0.049 DBMET02890 0.068 0.06 DBMET02883 0.085 0.037 DBMET02884 | DBMET02888 | |
| 0.098 | 0.053 | 0.115 | Toll-Like receptor 3 antagonist | 0.107 0.041 DBMET02878 0.101 0.049 DBMET02882 0.106 0.043 DBMET02888 0.086 0.077 DBMET02890 0.108 0.04 DBMET02879 0.105 0.044 DBMET02880 0.087 0.076 DBMET02883 0.115 0.033 DBMET02884 | DBMET02884 | |
| 0.11 | 0.067 | 0.112 | Activin receptor-like kinase 4 inhibitor | 0.105 0.075 DBMET02882 0.111 0.065 DBMET02888 0.1 0.086 DBMET02890 0.107 0.071 DBMET02883 0.112 0.063 DBMET02884 | DBMET02884 | |
| 0.127 | 0.107 | 0.127 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.106 | 0.086 | 0.127 | Protein kinase (CK1) delta inhibitor | 0.1 0.092 DBMET02882 0.127 0.068 DBMET02888 0.098 0.094 DBMET02880 0.126 0.069 DBMET02884 | DBMET02888 | |
| 0.089 | 0.072 | 0.109 | MAP kinase 9 inhibitor | 0.109 0.056 DBMET02888 0.103 0.06 DBMET02884 | DBMET02888 | |
| 0.115 | 0.103 | 0.121 | Protein kinase (CK1) gamma 1 inhibitor | 0.12 0.097 DBMET02888 0.121 0.096 DBMET02884 | DBMET02884 | |
| 0.046 | 0.034 | 0.048 | Baculoviral IAP repeat-containing protein inhibitor | 0.044 0.039 DBMET02882 0.045 0.036 DBMET02889 0.048 0.026 DBMET02884 | DBMET02884 | |
| 0.089 | 0.078 | 0.103 | Insulin receptor antagonist | 0.098 0.064 DBMET02888 0.103 0.057 DBMET02883 0.098 0.065 DBMET02884 | DBMET02883 | |
| 0.11 | 0.102 | 0.136 | Protein kinase (CK1) gamma inhibitor | 0.136 0.076 DBMET02888 0.117 0.094 DBMET02884 | DBMET02888 | |
| 0.025 | 0.018 | 0.03 | 5 Hydroxytryptamine 1F agonist | 0.024 0.019 DBMET02882 0.024 0.021 DBMET02888 0.03 0.013 DBMET02884 | DBMET02884 | |
| 0.146 | 0.14 | 0.168 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.152 0.13 DBMET02880 0.168 0.109 DBMET02884 | DBMET02884 | |
| 0.04 | 0.042 | 0.041 | Dipeptidyl peptidase IV inhibitor | 0.041 0.039 DBMET02884 | DBMET02884 | |
| 0.065 | 0.068 | 0.07 | Phosphodiesterase VIII inhibitor | 0.07 0.053 DBMET02884 | DBMET02884 | |
| 0.098 | 0.101 | 0.113 | MAP kinase 12 inhibitor | 0.101 0.097 DBMET02888 0.113 0.078 DBMET02884 | DBMET02884 | |
| 0.046 | 0.057 | 0.058 | Bombesin 3 receptor antagonist | 0.058 0.034 DBMET02884 | DBMET02884 | |
| 0.212 | 0.223 | 0.225 | Analgesic | 0.225 0.208 DBMET02890 0.225 0.208 DBMET02884 | DBMET02884 | |
| 0.043 | 0.055 | 0.063 | Acetylcholine M2 receptor agonist | 0.063 0.025 DBMET02888 | DBMET02888 | |
| 0.058 | 0.074 | 0.115 | ErbB-4 antagonist | 0.115 0.033 DBMET02878 0.081 0.052 DBMET02881 0.093 0.044 DBMET02879 | DBMET02878 | |
| 0.03 | 0.048 | 0.05 | MAP3K5 inhibitor | 0.038 0.028 DBMET02882 0.05 0.012 DBMET02883 0.043 0.02 DBMET02884 | DBMET02883 | |
| 0.068 | 0.09 | 0.093 | Fibroblast growth factor 1 antagonist | 0.093 0.063 DBMET02888 | DBMET02888 | |
| 0.054 | 0.08 | 0.069 | Histone deacetylase SIRT1 stimulant | 0.069 0.056 DBMET02880 | DBMET02880 | |
| 0.054 | 0.08 | 0.069 | Histone deacetylase stimulant | 0.069 0.056 DBMET02880 | DBMET02880 | |
| 0.052 | 0.079 | 0.069 | Polo-like kinase-2 inhibitor | 0.069 0.055 DBMET02888 | DBMET02888 | |
| 0.082 | 0.111 | 0.099 | mTOR complex 1 inhibitor | 0.099 0.064 DBMET02884 | DBMET02884 | |
| 0.052 | 0.081 | 0.062 | Protein kinase B alpha inhibitor | 0.062 0.058 DBMET02888 | DBMET02888 | |
| 0.091 | 0.129 | 0.123 | Ribosomal protein S6 kinase inhibitor | 0.123 0.087 DBMET02888 0.114 0.098 DBMET02884 | DBMET02888 | |
| 0.034 | 0.074 | 0.069 | Toll-Like receptor 8 antagonist | 0.069 0.024 DBMET02884 | DBMET02884 | |
| 0.08 | 0.122 | 0.165 | Folate antagonist | 0.105 0.056 DBMET02878 0.128 0.033 DBMET02881 0.108 0.051 DBMET02885 0.106 0.055 DBMET02879 0.165 0.017 DBMET02880 0.102 0.061 DBMET02884 0.097 0.07 DBMET02887 | DBMET02880 | |
| 0.049 | 0.102 | 0.069 | Fibroblast growth factor 3 antagonist | 0.069 0.067 DBMET02888 | DBMET02888 | |
| 0.078 | 0.132 | 0.115 | Protein kinase (CK1) inhibitor | 0.115 0.096 DBMET02888 | DBMET02888 | |
| 0.066 | 0.125 | 0.091 | MAP kinase 8 inhibitor | 0.091 0.072 DBMET02888 | DBMET02888 | |
| 0.086 | 0.152 | 0.118 | Src kinase inhibitor | 0.118 0.11 DBMET02888 | DBMET02888 | |
| 0.06 | 0.135 | 0.106 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.104 0.083 DBMET02878 0.106 0.081 DBMET02879 | DBMET02879 | |
| 0.06 | 0.134 | 0.106 | Abl kinase inhibitor | 0.104 0.082 DBMET02878 0.106 0.081 DBMET02879 | DBMET02879 | |
| 0.085 | 0.161 | 0.134 | Interleukin 2 antagonist | 0.117 0.05 DBMET02878 0.115 0.053 DBMET02879 0.134 0.029 DBMET02880 | DBMET02880 | |
| 0.121 | 0.22 | 0.177 | Growth factor agonist | 0.177 0.09 DBMET02880 | DBMET02880 | |
| 0.073 | 0.175 | 0.121 | CDC-like kinase 2 inhibitor | 0.121 0.118 DBMET02888 | DBMET02888 | |
| 0.081 | 0.183 | 0.451 | Anticoagulant | 0.167 0.068 DBMET02885 0.451 0.013 DBMET02889 0.136 0.094 DBMET02880 0.139 0.09 DBMET02886 | DBMET02889 | |
| 0.066 | 0.178 | 0.105 | Phosphodiesterase inhibitor | 0.105 0.099 DBMET02888 | DBMET02888 | |
| 0.012 | 0.149 | 0.119 | Urokinase inhibitor | 0.119 0.012 DBMET02889 | DBMET02889 | |
| 0.005 | 0.159 | 0.128 | Factor X inhibitor | 0.128 0.008 DBMET02889 | DBMET02889 | |
| 0.022 | 0.204 | 0.042 | Guanylate cyclase stimulant | 0.042 0.034 DBMET02880 | DBMET02880 | |
| 0.12 | 0.306 | 0.277 | Peptidyltransferase inhibitor | 0.221 0.075 DBMET02878 0.2 0.099 DBMET02881 0.229 0.068 DBMET02885 0.178 0.132 DBMET02890 0.277 0.034 DBMET02879 0.183 0.123 DBMET02880 0.178 0.132 DBMET02883 0.237 0.06 DBMET02886 0.177 0.134 DBMET02887 | DBMET02879 | |
| 0.028 | 0.223 | 0.064 | Factor III inhibitor | 0.064 0.014 DBMET02889 | DBMET02889 | |
| 0.011 | 0.21 | 0.057 | Factor XIa inhibitor | 0.057 0.014 DBMET02889 | DBMET02889 | |
| 0.007 | 0.21 | 0.019 | Factor IX inhibitor | 0.019 0.013 DBMET02889 | DBMET02889 | |
| 0.157 | 0.37 | 0.252 | MAP kinase kinase 6 inhibitor | 0.252 0.187 DBMET02880 | DBMET02880 | |
| 0.106 | 0.319 | 0.191 | Angiogenesis inhibitor | 0.191 0.18 DBMET02880 | DBMET02880 | |
| 0.037 | 0.259 | 0.088 | Aminoacyl-tRNA synthetase inhibitor | 0.085 0.067 DBMET02885 0.088 0.061 DBMET02879 0.086 0.066 DBMET02880 | DBMET02879 | |
| 0.024 | 0.251 | 0.087 | Bcr-Abl kinase inhibitor | 0.087 0.055 DBMET02878 | DBMET02878 | |
| 0.031 | 0.265 | 0.064 | Kallikrein 1 inhibitor | 0.064 0.029 DBMET02889 | DBMET02889 | |
| 0.009 | 0.257 | 0.124 | Factor VIIa inhibitor | 0.124 0.009 DBMET02889 | DBMET02889 | |
| 0.086 | 0.34 | 0.206 | Superoxide dismutase inhibitor | 0.206 0.111 DBMET02880 0.172 0.153 DBMET02884 | DBMET02880 | |
| 0.02 | 0.293 | 0.126 | Thrombin inhibitor | 0.126 0.016 DBMET02889 | DBMET02889 | |
| 0.075 | 0.374 | 0.188 | Lipocortins synthesis antagonist | 0.188 0.065 DBMET02881 | DBMET02881 | |
| 0.02 | 0.321 | 0.057 | Factor IXa inhibitor | 0.057 0.029 DBMET02889 | DBMET02889 | |
| 0.005 | 0.306 | 0.038 | Factor XI inhibitor | 0.038 0.018 DBMET02889 | DBMET02889 | |
| 0.097 | 0.413 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.118 DBMET02880 | DBMET02880 | |
| 0.005 | 0.331 | 0.095 | Kinesin-like protein 1 inhibitor | 0.095 0.008 DBMET02887 | DBMET02887 | |
| 0.005 | 0.331 | 0.095 | Kinesin antagonist | 0.095 0.008 DBMET02887 | DBMET02887 | |
| 0.054 | 0.38 | 0.133 | Interleukin 6 antagonist | 0.133 0.119 DBMET02880 | DBMET02880 | |
| 0.005 | 0.351 | 0.049 | Factor VII inhibitor | 0.049 0.012 DBMET02889 | DBMET02889 | |
| 0.069 | 0.418 | 0.173 | Hypoglycemic | 0.173 0.143 DBMET02881 0.164 0.156 DBMET02879 | DBMET02881 | |
| 0.042 | 0.412 | 0.107 | Hematopoietic | 0.107 0.03 DBMET02885 0.08 0.072 DBMET02880 0.091 0.047 DBMET02886 | DBMET02885 | |
| 0.12 | 0.511 | 0.231 | Calcium channel L-type activator | 0.231 0.228 DBMET02879 | DBMET02879 | |
| 0.082 | 0.488 | 0.212 | GABA C receptor rho-3 antagonist | 0.212 0.192 DBMET02881 | DBMET02881 | |
| 0.039 | 0.452 | 0.109 | Interleukin 4 antagonist | 0.109 0.102 DBMET02880 | DBMET02880 | |
| 0.004 | 0.425 | 0.048 | Trypsin I inhibitor | 0.048 0.013 DBMET02889 | DBMET02889 | |
| 0.024 | 0.445 | 0.196 | Thrombolytic | 0.123 0.106 DBMET02881 0.196 0.054 DBMET02885 0.116 0.115 DBMET02880 0.124 0.106 DBMET02886 | DBMET02885 | |
| 0.072 | 0.5 | 0.329 | Sodium/bile acid cotransporter inhibitor | 0.289 0.089 DBMET02881 0.329 0.055 DBMET02885 0.246 0.132 DBMET02879 0.209 0.176 DBMET02880 0.303 0.076 DBMET02886 | DBMET02885 | |
| 0.009 | 0.443 | 0.045 | Kallikrein inhibitor | 0.045 0.036 DBMET02889 | DBMET02889 | |
| 0.017 | 0.453 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.03 DBMET02887 | DBMET02887 | |
| 0.032 | 0.475 | 0.271 | Interleukin antagonist | 0.271 0.055 DBMET02885 0.147 0.12 DBMET02879 0.207 0.08 DBMET02880 0.135 0.13 DBMET02886 | DBMET02885 | |
| 0.007 | 0.459 | 0.058 | Plasmin inhibitor | 0.058 0.028 DBMET02889 | DBMET02889 | |
| 0.087 | 0.55 | 0.234 | Interleukin 2 agonist | 0.234 0.137 DBMET02885 0.211 0.171 DBMET02884 0.197 0.194 DBMET02886 0.212 0.169 DBMET02887 | DBMET02885 | |
| 0.003 | 0.47 | 0.045 | GP IIb/IIIa receptor antagonist | 0.045 0.037 DBMET02889 | DBMET02889 | |
| 0.047 | 0.516 | 0.19 | Histone acetyltransferase inhibitor | 0.19 0.084 DBMET02880 | DBMET02880 | |
| 0.048 | 0.537 | 0.146 | Growth hormone agonist | 0.146 0.09 DBMET02885 | DBMET02885 | |
| 0.022 | 0.542 | 0.233 | Angiogenesis stimulant | 0.185 0.103 DBMET02881 0.233 0.078 DBMET02885 0.19 0.1 DBMET02880 0.174 0.108 DBMET02886 | DBMET02885 | |
| 0.016 | 0.538 | 0.102 | Trypsin inhibitor | 0.102 0.016 DBMET02889 | DBMET02889 | |
| 0.025 | 0.56 | 0.33 | Cytokine production inhibitor | 0.33 0.012 DBMET02880 | DBMET02880 | |
| 0.008 | 0.546 | 0.104 | Plasminogen activator inhibitor | 0.104 0.014 DBMET02889 | DBMET02889 | |
| 0.035 | 0.597 | 0.231 | Antithrombotic | 0.231 0.142 DBMET02881 0.204 0.172 DBMET02880 | DBMET02881 | |
| 0.004 | 0.582 | 0.038 | Trypsin II inhibitor | 0.038 0.014 DBMET02889 | DBMET02889 | |
| 0.046 | 0.628 | 0.239 | Vasodilator, peripheral | 0.239 0.136 DBMET02881 | DBMET02881 | |
| 0.016 | 0.623 | 0.193 | Platelet antagonist | 0.193 0.106 DBMET02889 0.175 0.122 DBMET02880 | DBMET02889 | |
| 0.016 | 0.625 | 0.083 | Chymotrypsin inhibitor | 0.083 0.051 DBMET02882 | DBMET02882 | |
| 0.009 | 0.663 | 0.699 | Cell adhesion molecule inhibitor | 0.489 0.004 DBMET02878 0.549 0.004 DBMET02881 0.699 0.003 DBMET02880 | DBMET02880 | |
| 0.002 | 0.673 | 0.045 | Ornithine carbamoyltransferase inhibitor | 0.045 0.044 DBMET02881 | DBMET02881 | |
| 0.024 | 0.704 | 0.121 | Adenylate kinase inhibitor | 0.121 0.043 DBMET02881 | DBMET02881 | |
| 0.003 | 0.693 | 0.056 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.036 DBMET02881 | DBMET02881 | |
| 0.036 | 0.727 | 0.105 | Factor V inhibitor | 0.105 0.059 DBMET02881 0.102 0.065 DBMET02885 | DBMET02881 | |
| 0.02 | 0.747 | 0.319 | Immunosuppressant | 0.319 0.104 DBMET02885 0.295 0.118 DBMET02886 0.294 0.119 DBMET02887 | DBMET02885 | |
| 0.012 | 0.753 | 0.577 | Cell adhesion inhibitor | 0.387 0.005 DBMET02878 0.443 0.005 DBMET02881 0.577 0.004 DBMET02880 | DBMET02880 | |
| 0.004 | 0.755 | 0.087 | Alcohol dehydrogenase inhibitor | 0.087 0.068 DBMET02881 0.081 0.078 DBMET02880 | DBMET02881 | |
| 0.015 | 0.803 | 0.112 | Electron transport complex I inhibitor | 0.112 0.059 DBMET02879 | DBMET02879 | |
| 0.006 | 0.837 | 0.202 | Immunostimulant | 0.202 0.119 DBMET02885 | DBMET02885 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |